Prognostic Value of PCNA and Mutant p53 Expression in Laryngeal Squamous Cell Carcinoma
暂无分享,去创建一个
[1] K. Hemminki,et al. Alteration of p53 gene structure and function in laryngeal squamous cell cancer , 2006, European Archives of Oto-Rhino-Laryngology.
[2] H. VallésVarela,et al. Immunohistochemical markers of cell proliferation in laryngeal carcinoma , 2000 .
[3] J. Valencia Julve,et al. [Immunohistochemical markers of cell proliferation in laryngeal carcinoma]. , 2000, Acta otorrinolaringologica espanola.
[4] G. Gedıkoğlu,et al. Prognostic significance of histopathological parameters in cancer of the larynx , 1999, European Archives of Oto-Rhino-Laryngology.
[5] J. Ryś,et al. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx. , 1998, Auris, nasus, larynx.
[6] A. El‐Naggar,et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl‐2 in laryngeal squamous cell carcinoma , 1998, Cancer.
[7] W. Golusiñski,et al. Retrospektive Analyse ausgewählter Tumormarker (p53, PCNA, Ki67; DNA-Ploidie) und der Ultrastruktur bei Kranken mit Larynxkarzinomen , 1998, HNO.
[8] J. Olofsson,et al. [Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas]. , 1998, HNO.
[9] V. Kosma,et al. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] S. Fukushima,et al. Prognostic significance of the MIB‐1 proliferation index for patients with squamous cell carcinoma of the esophagus , 1995, Cancer.
[11] H. Dienes,et al. Predicting Recurrence and Survival in Patients with Laryngeal Cancer by Means of DNA Cytometry, Tumor Front Grading, and Proliferation Markers , 1995, The Annals of otology, rhinology, and laryngology.
[12] S. Syrjänen,et al. Implications of the p53 tumor-suppressor gene in clinical oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Armand,et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. , 1995, Oncogene.
[14] E. Campo,et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors , 1995, The Journal of pathology.
[15] P. Bradley,et al. Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. , 1994, American journal of surgery.
[16] G. Dardanoni,et al. P53 expression in stage iii-iv squamous-cell carcinoma of the larynx - an immunohistochemical study related to clinicopathological, flow-cytometric DNA analysis and prognosis. , 1994, International journal of oncology.
[17] A. Cuschieri,et al. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. , 1994, British Journal of Cancer.
[18] A. Malliri,et al. P53 expression in end-stage squamous-cell carcinoma of the head and neck prior to chemotherapy treatment - expression correlates with a very poor clinical outcome. , 1993, International journal of oncology.
[19] Hannu,et al. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. , 1993, The American journal of pathology.
[20] H. Sasano,et al. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. , 1992, Human pathology.
[21] R. Maestro,et al. p53 over‐expression is an early event in the development of human squamous‐cell carcinoma of the larynx: Genetic and prognostic implications , 1992, International journal of cancer.
[22] J Vasko,et al. Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[23] R. Maestro,et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. , 1992, Oncogene.
[24] F. Demard,et al. The labelling index: a prognostic factor in head and neck carcinoma. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] A. Levine,et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.
[26] C. Muir,et al. Estimates of the worldwide frequency of twelve major cancers. , 1984, Bulletin of the World Health Organization.